chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 minutes post-injection onset of nausea.  10 minutes post-injection retching.  1 hour post injection intense abdominal pain.  2 hours post injection onset of full body itching with no rash or hives.  Itching responded to 50 mg Benadryl po and 20 mg po pepcid.  Next day light itching; no other symptoms
7.11.21: Patient presents to ER with shortness of breath. Has history of receiving Pfizer COVID-19 vaccine on 4/16/21. Found to be hypoxic and COVID-19 positive. diagnosed with acute hypoxic respiratory failure and viral sepsis due to COVID.  Started Remdesivir.  7.15.21: completed 5 day course of remdesivir. discharged home.
This patient was due to the second dose of primary series on covid19 Pfizer grey cap 12+, instead they received the bivalent booster. No adverse reactions have been reported so far
Stroke; A spontaneous report was received from a consumer who was also a 76-years-old female patient, who received Moderna's covid-19 vaccine (mRNA-1273) and who experienced stroke (stroke).  The patient's medical history was not provided. Concomitant medications were not reported.  On 13 FEB 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 23 FEB 2021, the patient had a stroke leading to hospitalization. Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was unknown.  At the time of this report, the outcome of the event stroke was unknown.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
pulsating feeling in her left arm, in her muscle; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (pulsating feeling in her left arm, in her muscle) and VACCINATION SITE PAIN (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 31-Jan-2021, the patient experienced NERVOUSNESS (pulsating feeling in her left arm, in her muscle). On 31-Jan-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, NERVOUSNESS (pulsating feeling in her left arm, in her muscle) had not resolved.            No concomitant product was reported.   No treatment information was reported.
Approx. 10 hours after vacc. given c/o discomfort, redness, & swelling just below injection site on (L) arm; area continued to increase with edema until "all loose skin was tight"; c/o area hot to touch. Much improved after 3 days. (PNEUMOVAX given in left arm).
had a knot on her arm where the shot was administered; where the shot was administered that was itching; where the shot was administered that was redness; where the shot was administered that was swelling; This is a spontaneous report from a contactable consumer (patient herself). A 56-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on left arm, via unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunization. Medical history included she was exposed to Covid from a patient she was working with that came back positive on 05Jan2021 which exposed to Covid was prior to taking the shot. Concomitant medications were reported as none. Reporter stated that she came in last week and took Pfizer shot. Stated before the shot that she was exposed to Covid from a patient she was working with that came back positive. Wanted to know if she took Covid test would it come back positive automatically. Wanted to know if she was allowed to take the Covid test. She had on all of her PPE gear and N95 mask. She screened the patient but the patient had a mask on, she worked in dental, for a time period he that the patient had his mask off for a short time period. Stated that this was for the Pfizer Covid 19 shot, it was her first shot and she would take the second shot on 26Jan. Reporter was a dental assistant and calling on behalf of herself. Stated that she had a knot on her arm where the shot was administered that was swelling, red and itching on 06Jan2021. Stated that the knot was almost not there. Later stated that the knot was gone Saturday 09Jan. The outcome of event "where the shot was administered that was itching" was resolving while outcome of other events were resolved on 09Jan2021.  Information about lot/batch number has been requested.
Information had been received on 19-APR-2017 regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, lot # and expiration date were not provided) on or about 13-JUL-2011 by a physician, as recommended for routine adult health maintenance for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported that the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-NOV-2011, the patient was treated by the physician for an ongoing painful rash which was diagnosed as a shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested. Sender's Comments: US-009507513-1704USA009733.
pt recv vax 17MAR97 & 29MAR97 pt devel a rash & lymphadenopathy;
Narrative: 73 yo male died of unknown cause at unknown place and unknown circumstances on 11/29/22. Pt had received a COVID vaccine EUA (J&J) on 9/7/2021. Reporting since death on EUA vaccine. Likely this death was not related to the covid vaccine given the long time frame between date vaccine was given and the date of patient's death.
Developed pneumonia after the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Developed pneumonia after the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (The patient was allergic to Bactrim, because hand was turning red and developed a rash on the face, back and itching hands.).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Developed pneumonia after the vaccine) (seriousness criteria death, hospitalization and medically significant). The patient was hospitalized for 8 days due to PNEUMONIA. The patient was treated with ZOLEDRONIC ACID (RECLAST) for Adverse event, at an unspecified dose and frequency. The reported cause of death was Pneumonia. It is unknown if an autopsy was performed.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: low (Low) low.         No concomitant medications were reported.  Company Comment: This case concerns a patient with of unknown age and gender, as well as unknown medical history, who experienced the unexpected event of pneumonia that ended with fatal outcome. The temporal relationship remained unknown having in mind that the date of vaccination and date of the event were not provided. If was unknown if the autopsy was performed. The rechallenge was not applicable, as the event ended with fatal outcome. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-325775, MOD-2021-325636 (Patient Link).; Sender's Comments: This case concerns a patient with of unknown age and gender, as well as unknown medical history, who experienced the unexpected event of pneumonia that ended with fatal outcome. The temporal relationship remained unknown having in mind that the date of vaccination and date of the event were not provided. If was unknown if the autopsy was performed. The rechallenge was not applicable, as the event ended with fatal outcome. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.; Reported Cause(s) of Death: Pneumonia
Upper left arm is red, swollen and warm at injection site. Symptoms did not appear until one week after injection. Treating with ice pack and Tylenol, although neither seems to have much effect.
fever, body aches, joint pain, extreme headache , foggy brain, abdominal pain . lasted about 2 weeks.
Over a week later, injection site red, swollen, warm to the touch, sore, and a small amount of blood
This literature report concerns a series of 10 fatalities cases after H1N1 vaccinations. These 10 cases involved 2 children, 7 adults and 1 elderly reported. This case (2 of 10) concerns a 2-year-old female patient, who had a medical history of encephalopathy, central apnea, traumatic brain damage, seizures. The patient died of sudden death cardiopulmonary arrest after H1N1 vaccination (type: monovalent inactivated, split-virus vaccine; manufacture: unknown). Time to onset was 0 day. Reporters comment: VAERS (Vaccine Adverse Event Reporting System) received 13 reports of deaths occurring after receipt of H1N1 vaccine; 3 deaths occurred after receipt of LAMV (live, attenuated monovalent vaccine) and 10 after receipt of MIV (monovalent inactivated, split-virus or subunit vaccines). In 9 of these deaths, significant underlying illness (including illness that might be indication for vaccination) was present; 1 death resulted from a motor vehicle crash, and the remaining 3 deaths await review of final autopsy results or death certificates by CDC (Centers for Disease Control).
flu shot, patient wear masks & follow the guidelines & yet right now patient ws sick with the flu; Initial information received on 07-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involved a patient of unknown age who got flu shot, patient wear masks & follow the guidelines & yet right now patient was sick with the flu (influenza), while patient received vaccines INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received INFLUENZA VACCINE [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, patient got flu shot, patient wear masks & follow the guidelines & yet right now patient was sick with the flu (influenza), (latency: unknown) following the administration of suspect vaccine.  Relevant laboratory test results included: COVID-19 - On an unknown date: Negative [tested for Covid & it was negative].  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Headache; Chills; Aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Aches). At the time of the report, HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided.
Goose-sized egg bump, very red with rash, hot to the touch. Used cold water and hydrocortisone then by the evening time swelling reduced. Next day 2-5-2021 bump was gone but still red and itchy.
Cellulitis of upper left arm; first appeared 05/02/2016 and patient saw MD on 05/10/2016. Treated with cephalexin 500 mg 3 x daily x 10 days. Affected area from elbow to shoulder.
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 6-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
Pt. states that after receiving the 2nd dose of Moderna 04/21/2021, started experiencing symptoms 04/22/2021 morning suffering from full body Stroke. Pt. has made a full recovery.
Five days after the vaccine shot, I suddenly lost hearing in my left hear and could only hear a very load buzzing sound. The next morning I went for an emergency visit to my ear doctor who did several tests, along with a hearing test. I had lost about 50% of my hearing in that ear. These test were done on 10/18/23.  The diagnosis was acoustic nerve inflammation, probably caused by a virus. Since I had not been sick all for many months, the only virus I was knowingly exposed to was the Covid vaccine. I was given 12 days of prednisone and omeprazole. So far after 2 days, some of hearing has returned, however, the buzzing is still prominent.
When I got my first shot I felt like I was having Covid all over again. I got the same symptoms I had when I got Covid on December 8th. My taste got better. I could smell from miles away. Everything hurt. Every injury I had before started hurting. It went to my bowels. I have not had hemorrhoids since I had my baby at 40 years old. Now I do. Now it feels like I am on my period every year because it makes me bleed. This time it feels like it is going to my lungs. It is also attacking my heart. It is attacking every old injury it had. My doctor suggested me to take an x-ray because my ribs were hurting on the left side. I don?t know if I had pull a muscle. I got the booster last week but it started hurting before that. I had the x-ray but I do not have the results back yet. I also got a Covid test and influenza test. I got Covid. I am working at a high school and there is no safety guidelines there.
Soreness around the injection site, pain in the area of the arm where the shots were applied; 17 yr old Pediatric Patient received the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old Pediatric Patient received the first dose) and VACCINATION SITE PAIN (Soreness around the injection site, pain in the area of the arm where the shots were applied) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 017C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old Pediatric Patient received the first dose). On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness around the injection site, pain in the area of the arm where the shots were applied). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old Pediatric Patient received the first dose) had resolved and VACCINATION SITE PAIN (Soreness around the injection site, pain in the area of the arm where the shots were applied) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported include Multivitamin Gummies Kirkland and Probiotic Gummies Schiff.  Treatment information was not provided   This case was linked to MOD-2021-132637 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up received  contain significant follow up information included patient demographic details- race updated, Product information updated for both doses, 1st dose start date updated. On 20-Jul-2021: Non Significant Follow up: Patient demographics again changed. Product information 1st dose date changed back to 14-4-2021
Moderna arm; people are getting urticaria on injection site and it spreads; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE REACTION (Moderna arm) and VACCINATION SITE URTICARIA (people are getting urticaria on injection site and it spreads) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Moderna arm) and VACCINATION SITE URTICARIA (people are getting urticaria on injection site and it spreads). At the time of the report, VACCINATION SITE REACTION (Moderna arm) and VACCINATION SITE URTICARIA (people are getting urticaria on injection site and it spreads) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter stated that she read about the Moderna arm, where people were getting urticaria on injection site and it spreads.   No concomitant medications were reported.  No treatment medications were reported.
High temp  Nausea Diarrhea  Headache Weakness  Faint/woozy
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Dec2020 at 14:30 as dose 1, single (Batch/Lot number: unknown), in left arm, on 19Jan2021 at 08:00 as dose 2, single (Batch/Lot number: unknown), in left arm and on 01Oct2021 at 16:00 as dose 3 (booster), single (Lot number: 30145BA) at the age of 33 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "PTSD" (unspecified if ongoing). Concomitant medication(s) included: PRISTIQ, start date: 07Aug2019; WELLBUTRIN, start date: 08Jan2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 included Paxlovid from 05Aug2022 to 09Aug2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information currently available, a causal association between the reported event and BNT162b2 cannot be excluded.
This is a  14 Years old  Male  presenting with chest pain for 2 hours. Pain started gradually. It is described as tightness and non-radiating. Pain is described as moderate upon onset and is currently mild.  No history of the same.  Patient also notes associated symptoms of shortness of breath with the chest tightness.  Pain is not worse with exercise. Patient has no decrease in exercise tolerance recently.
diverticulitis; This is a spontaneous report from a contactable nurse from a Pfizer-sponsored program. A 72-year-old male patient received the first dose on BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 23Jan2021 as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient developed diverticulitis and was on 2 antibiotics (not specified). It was reported that it was not a bad or severe bout. The clinical outcome of the event diverticulitis was unknown.   No follow-up attempts are possible; information about lot number cannot be obtained.